AAAAAA

   
Results: 1-22 |
Results: 22
RESOURCE COSTING FOR MULTINATIONAL NEUROLOGIC CLINICAL-TRIALS - METHODS AND RESULTS
Authors: SCHULMAN K BURKE J DRUMMOND M DAVIES L CARLSSON P GRUGER J HARRIS A LUCIONI C GISBERT R LLANA T TOM E BLOOM B WILLKE R GLICK H
Citation: K. Schulman et al., RESOURCE COSTING FOR MULTINATIONAL NEUROLOGIC CLINICAL-TRIALS - METHODS AND RESULTS, Health economics, 7(7), 1998, pp. 629-638
A COMPARISON OF METHODS FOR ACCOUNTING FOR TRUNCATED TRIALS OF LIFETIME THERAPIES
Authors: GLICK H COOK J HEYSE J KINOSIAN B
Citation: H. Glick et al., A COMPARISON OF METHODS FOR ACCOUNTING FOR TRUNCATED TRIALS OF LIFETIME THERAPIES, Medical decision making, 18(4), 1998, pp. 463-463
WOULD MANICS RATHER LAND - FUNCTION AND QUALITY-OF-LIFE IN PATIENTS WITH BIPOLAR DISORDER
Authors: VOJTA CL GLICK H BAUER MS KINOSIAN B
Citation: Cl. Vojta et al., WOULD MANICS RATHER LAND - FUNCTION AND QUALITY-OF-LIFE IN PATIENTS WITH BIPOLAR DISORDER, Medical decision making, 18(4), 1998, pp. 490-490
ECONOMIC-ANALYSIS OF TIRILAZAD MESYLATE FOR ANEURYSMAL SUBARACHNOID HEMORRHAGE - ECONOMIC-EVALUATION OF A PHASE-III CLINICAL-TRIAL IN EUROPE AND AUSTRALIA
Authors: GLICK H WILLKE R POLSKY D LLANA T ALVES WM KASSELL N SCHULMAN K
Citation: H. Glick et al., ECONOMIC-ANALYSIS OF TIRILAZAD MESYLATE FOR ANEURYSMAL SUBARACHNOID HEMORRHAGE - ECONOMIC-EVALUATION OF A PHASE-III CLINICAL-TRIAL IN EUROPE AND AUSTRALIA, International journal of technology assessment in health care, 14(1), 1998, pp. 145-160
PREDICTING 5-YEAR OUTCOMES OF ALZHEIMERS-DISEASE
Authors: KINOSIAN B STALLARD E LEE J WOODBURY M BERZON R ZBROSEK A SMITH ME GLICK H
Citation: B. Kinosian et al., PREDICTING 5-YEAR OUTCOMES OF ALZHEIMERS-DISEASE, Journal of the American Geriatrics Society, 46(9), 1998, pp. 213-213
A COMPARISON OF THE MINI-MENTAL-STATE-EXAM AND THE SHORT PORTABLE MENTAL STATUS QUESTIONNAIRE IN ALZHEIMERS-DISEASE
Authors: LEE J KINOSIAN B STALLARD E WOODBURY M BERZON R ZBROSEK A GLICK H
Citation: J. Lee et al., A COMPARISON OF THE MINI-MENTAL-STATE-EXAM AND THE SHORT PORTABLE MENTAL STATUS QUESTIONNAIRE IN ALZHEIMERS-DISEASE, Journal of the American Geriatrics Society, 46(9), 1998, pp. 321-321
COST-EFFECTIVENESS OF LDL-C REDUCTION IN MEDICARE MANAGED CARE CHD PATIENTS - IMPLICATIONS FROM THE SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY(4S)
Authors: SCHWARTZ JS BOCCUZZI SJ MURRAY JF ROEHM JB COOK JR GLICK H KINOSIAN B PEDERSEN T KJEKSHUS J
Citation: Js. Schwartz et al., COST-EFFECTIVENESS OF LDL-C REDUCTION IN MEDICARE MANAGED CARE CHD PATIENTS - IMPLICATIONS FROM THE SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY(4S), Journal of the American College of Cardiology, 29(2), 1997, pp. 7672-7672
THE ECONOMIC-IMPACT OF PROPHYLACTIC DEFIBRILLATORS
Authors: BOYKO W SCHULMAN KA TRACY CM GLICK H SOLOMON AJ
Citation: W. Boyko et al., THE ECONOMIC-IMPACT OF PROPHYLACTIC DEFIBRILLATORS, Journal of the American College of Cardiology, 29(2), 1997, pp. 83129-83129
A NEW LOW-DOSE MONOPHASIC COMBINATION ORAL-CONTRACEPTIVE (ALESSE(TM))WITH LEVONORGESTREL-100-MU-G AND ETHINYL-ESTRADIOL-20-MU-G
Authors: ARCHER DF MAHEUX R DELCONTE A OBRIEN FB ADAMS D APPEL T BROWN D CARR B CHENAULT B CONNELL E DAVILA G DONOVAN S FAGUANT R GLICK H GRIMES D HANSON M HARRIS JW HUME J KASPARIAN S KATZ D LIFSON MS MERCER L MERRITT D MOORE D SCHADE G SPELLACY W STEPHENSON CD STEWART SK THORP JM VARNER E WALLACH E BLANCHET P BORODITSKY R CHOQUETTE P GUILBERT E LEFEBVRE Y POWELL MG ROSS S SENIKAS V YOUNG R YUZPE A
Citation: Df. Archer et al., A NEW LOW-DOSE MONOPHASIC COMBINATION ORAL-CONTRACEPTIVE (ALESSE(TM))WITH LEVONORGESTREL-100-MU-G AND ETHINYL-ESTRADIOL-20-MU-G, Contraception, 55(3), 1997, pp. 139-144
COST-EFFECTIVENESS OF LDL-C REDUCTION IN DIABETIC CHD PATIENTS - IMPLICATIONS FROM THE SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY (4S)
Authors: SCHWARTZ JS BROCCUZZI SJ GLICK H COOK JR KINOSIAN B DAVIS L PEDERSEN TR KJEKSHUS J
Citation: Js. Schwartz et al., COST-EFFECTIVENESS OF LDL-C REDUCTION IN DIABETIC CHD PATIENTS - IMPLICATIONS FROM THE SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY (4S), Circulation, 96(8), 1997, pp. 2827-2827
THE ECONOMIC COST OF HIP-FRACTURES IN COMMUNITY-DWELLING OLDER ADULTS- A PROSPECTIVE-STUDY
Authors: BRAINSKY A GLICK H LYDICK E EPSTEIN R FOX KM HAWKES W KASHNER TM ZIMMERMAN SI MAGAZINER J
Citation: A. Brainsky et al., THE ECONOMIC COST OF HIP-FRACTURES IN COMMUNITY-DWELLING OLDER ADULTS- A PROSPECTIVE-STUDY, Journal of the American Geriatrics Society, 45(3), 1997, pp. 281-287
A STRATEGY FOR COLLECTING PHARMACOECONOMIC DATA DURING PHASE II III CLINICAL-TRIALS/
Authors: MAUSKOPF J SCHULMAN K BELL L GLICK H
Citation: J. Mauskopf et al., A STRATEGY FOR COLLECTING PHARMACOECONOMIC DATA DURING PHASE II III CLINICAL-TRIALS/, PharmacoEconomics, 9(3), 1996, pp. 264-277
RESULTS OF THE ECONOMIC-EVALUATION OF THE FIRST STUDY - A MULTINATIONAL PROSPECTIVE ECONOMIC-EVALUATION
Authors: SCHULMAN KA BUXTON M GLICK H SCULPHER M GUZMAN G KONG J BACKHOUSE M MAUSKOPF J BELL L EISENBERG JM CALIFF RM MCKENNA WJ HARRELL FE URETSKY BF ADAMS KF SWEDBERG KB GHEORGHIADE M ZANNAD F HANDBERG E DARIUS H SOLERSOLER J WHEELER WS ARMSTRONG PW PATTERSON H MURALI S BUTMAN S KIRLIN PC MILLER LW JAFRI S RICH S COSTANZONORDIN MR MCGOON M HOSENPUD JD RATKOVEC R BRUNDAGE B PRITZKER M BOURGE R REEVES W FORGOSH L VENTURA H YOUNG JB MANCINI D MILLS RM LIMACHER MC LEE F REVKIN J KALBFLEISCH JM FISHBEIN D PRESSLER M HAEUSSLEIN E KARLSBERG RP OCONNELL J LEJEMTEL TH THOMAS HM SMITH WB MCIVOR M CINTRON GB HAGER WD MESSINEO FC DOUGHERTY JE HASSAPOYANNES C HOOD W MCGREW F SANFORD CF OCONNER CM HOBBS RE YARDLEY D KAY R MINOTTI J EASTBURN TE LINDENFELD J LITMAN G WICKEMEYER W HORTON S GILBERT EM EICHORN E RIBNER HS CORDER C PHILBIN E NOCERO M ELKAYAM U JESSUP M CRAWFORD M CARSON P REDDY HK KLAPHOLZ M HEYWOOD JT SALINGER M KARLSBERG R BUSH D HUNTER C WOHNS D EISENBERG P WINSTON S BUTCHER C MASSIN E WYNNE J TONKON M SPACCAVENTO L DIVER D GHALI J HUTCHINS S ANAND I BEANLANDS D KOSTUK W PFLUGFELDER P LANGLEBEN D LATOUR P MIZGALA H RICCI D MANYARI D DARGIE HJ DAVIDSON C SWANTON H HUBNER PJB OAKLEY D BROOKS N JENNINGS K GREENBAUM RA PENNY WJ NICHOLLS P WALSH M SUGRUE D FENNELL W HORGAN JH JONDEAU G CASTAIGNE A LEMAREC H WALGER P PARK JW DEBERRAZUETA JR MOL MG SANCHEZ MAG CAPONNETTO S MAGNANI B GALIE N DEVITA C MASERI A BAGGER JP REMES J WALDENSTROM A SCHAUFELBERGER M DIENSTI F SIMOONS ML KLEIN W PACHER R KEOGH A HARLEY A
Citation: Ka. Schulman et al., RESULTS OF THE ECONOMIC-EVALUATION OF THE FIRST STUDY - A MULTINATIONAL PROSPECTIVE ECONOMIC-EVALUATION, International journal of technology assessment in health care, 12(4), 1996, pp. 698-713
THE ECONOMIC-EVALUATION OF THE FIRST STUDY - DESIGN OF A PROSPECTIVE ANALYSIS ALONGSIDE A MULTINATIONAL PHASE-III CLINICAL-TRIAL
Authors: SCHULMAN KA GLICK H BUXTON M SCULPHER M BACKHOUSE M BELL L EISENBERG JM
Citation: Ka. Schulman et al., THE ECONOMIC-EVALUATION OF THE FIRST STUDY - DESIGN OF A PROSPECTIVE ANALYSIS ALONGSIDE A MULTINATIONAL PHASE-III CLINICAL-TRIAL, Controlled clinical trials, 17(4), 1996, pp. 304-315
CHOLESTEROL AND CORONARY HEART-DISEASE - PREDICTING RISKS IN MEN BY CHANGES IN LEVELS AND RATIOS
Authors: KINOSIAN B GLICK H PREISS L PUDER KL
Citation: B. Kinosian et al., CHOLESTEROL AND CORONARY HEART-DISEASE - PREDICTING RISKS IN MEN BY CHANGES IN LEVELS AND RATIOS, Journal of investigative medicine, 43(5), 1995, pp. 443-450
THE COST AND BENEFITS OF ENALAPRIL THERAPY IN POST-MI PATIENTS WITH ASYMPTOMATIC LEFT-VENTRICULAR DYSFUNCTION
Authors: GLICK H COOK J PITT B KINOSIAN B BOURASSA M POULEUR H GERTH W
Citation: H. Glick et al., THE COST AND BENEFITS OF ENALAPRIL THERAPY IN POST-MI PATIENTS WITH ASYMPTOMATIC LEFT-VENTRICULAR DYSFUNCTION, Circulation, 92(8), 1995, pp. 2433-2433
AN AGGRESSIVE HIGH-DOSE CYCLOPHOSPHAMIDE AND PREDNISONE REGIMEN FOR ADVANCED MULTIPLE-MYELOMA
Authors: LENHARD RE DANIELS MJ OKEN MM GLICK H ETTINGER DS KALISH L OCONNELL MJ
Citation: Re. Lenhard et al., AN AGGRESSIVE HIGH-DOSE CYCLOPHOSPHAMIDE AND PREDNISONE REGIMEN FOR ADVANCED MULTIPLE-MYELOMA, Leukemia & lymphoma, 13(5-6), 1994, pp. 485-489
PROJECTIONS OF THE COST AND BENEFITS OF ENALAPRIL TREATMENT IN PATIENTS WITH SYMPTOMATIC HEART-FAILURE
Authors: GLICK H COOK J BOURASSA M PITT B POULEUR H KINOSIAN B CONTANDRIOPOULOS AP GERTH W
Citation: H. Glick et al., PROJECTIONS OF THE COST AND BENEFITS OF ENALAPRIL TREATMENT IN PATIENTS WITH SYMPTOMATIC HEART-FAILURE, Journal of the American College of Cardiology, 1994, pp. 10000284-10000284
CHOLESTEROL AND CORONARY HEART-DISEASE - PREDICTING RISKS BY LEVELS AND RATIOS
Authors: KINOSIAN B GLICK H GARLAND G
Citation: B. Kinosian et al., CHOLESTEROL AND CORONARY HEART-DISEASE - PREDICTING RISKS BY LEVELS AND RATIOS, Annals of internal medicine, 121(9), 1994, pp. 641-647
DEPRESSIVE SYMPTOMS AND DSM-III-R ALCOHOL DEPENDENCE - GENERAL-POPULATION RESULTS
Authors: HASIN DS GLICK H
Citation: Ds. Hasin et H. Glick, DEPRESSIVE SYMPTOMS AND DSM-III-R ALCOHOL DEPENDENCE - GENERAL-POPULATION RESULTS, Addiction, 88(10), 1993, pp. 1431-1436
PREMENSTRUAL CHANGES - ARE THEY FAMILIAL
Authors: GLICK H ENDICOTT J NEE J
Citation: H. Glick et al., PREMENSTRUAL CHANGES - ARE THEY FAMILIAL, Acta psychiatrica Scandinavica, 88(3), 1993, pp. 149-155
GLAUCOMA IN THE UNITED-STATES POPULATION - THE ECONOMIC BURDEN OF ILLNESS
Authors: GUZMAN G JAVITT J GLICK H TIELSCH J MACDONALD R
Citation: G. Guzman et al., GLAUCOMA IN THE UNITED-STATES POPULATION - THE ECONOMIC BURDEN OF ILLNESS, Investigative ophthalmology & visual science, 33(4), 1992, pp. 759-759
Risultati: 1-22 |